首页 > 最新文献

Urologia Journal最新文献

英文 中文
Retraction notice. 撤稿通知。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-12 DOI: 10.1177/03915603241288993
{"title":"Retraction notice.","authors":"","doi":"10.1177/03915603241288993","DOIUrl":"https://doi.org/10.1177/03915603241288993","url":null,"abstract":"","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603241288993"},"PeriodicalIF":0.8,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of the Rezūm System for lower urinary tract symptoms in patients with benign prostatic hyperplasia: Long term results from a single centre prospective study. Rezūm 系统对良性前列腺增生患者下尿路症状的疗效:单中心前瞻性研究的长期结果。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-08 DOI: 10.1177/03915603241297137
Angelo Totaro, Filippo Gavi, Daniele Fettucciari, Francesco Pio Bizzarri, Domenico Sanesi, Luigi Cosenza, Filippo Marino, Antonio Cretì, Pierluigi Russo, Emilio Sacco

Introduction: Benign prostatic hyperplasia (BPH) is a prevalent urological condition leading to lower urinary tract symptoms. Minimal invasive surgical treatment (MISTs) such as Rezūm System are emerging aiming to relieve symptoms. We present results from a single centre prospective study.

Methods: We prospectively followed patients undergoing Rezūm between 2021 and 2023 from a single centre. International Prostate Symptom Score (IPSS), functional outcomes (maximum urinary flow rate (Qmax) and post-void urinary residual (PVR) and International Index of Erectile Function-5 (IIEF-5) were assessed at 3, 6, 12 and 24 months. Anterograde ejaculation was assessed at 12 months follow up. Linear mixed-effects models (LMMs) for repeated measures were applied to assess differences in the IPSS, maximum flow rate (Qmax), PVR, and International Index of Erectile Function-5 (IIEF-5) from baseline (t0) to 3, 6, 12 and 24 months. Results: After adjusting for prostate volume and symptoms severity, significant differences were observed at 3, 6, 12 and 24 months for IPSS (p < 0.001), Qmax (p < 0.001), PVR (p < 0.001) and IPSS-QoL (p < 0.001) from baseline. No statistically significant changes were found in the IIEF-5 scores at 3, 6, 12 and 24 months from baseline. Anterograde ejaculation remained in 98% of patients after treatment.

Conclusions: In conclusion, the study's findings indicate that patients undergoing Rezūm treatment experience sustained improvements in IPSS, Qmax, PVR and IPSS-related quality of life up to 24 months following the intervention. Anterograde ejaculation remained in 98% of patients after treatment.

导言:良性前列腺增生症(BPH)是一种导致下尿路症状的常见泌尿系统疾病。以缓解症状为目的的微创手术治疗(MIST)(如 Rezūm 系统)正在兴起。我们展示了一项单中心前瞻性研究的结果:方法:我们对 2021 年至 2023 年期间在一个中心接受 Rezūm 治疗的患者进行了前瞻性随访。在3、6、12和24个月时评估国际前列腺症状评分(IPSS)、功能结果(最大尿流率(Qmax)和排尿后残余尿(PVR))以及国际勃起功能指数-5(IIEF-5)。随访 12 个月时对逆行射精进行评估。应用线性混合效应模型(LMMs)进行重复测量,以评估 IPSS、最大流速(Qmax)、PVR 和国际勃起功能指数-5(IIEF-5)从基线(t0)到 3、6、12 和 24 个月的差异。结果:调整前列腺体积和症状严重程度后,3、6、12 和 24 个月时的 IPSS 与基线相比有显著差异(p p p < 0.001)。IIEF-5评分在3个月、6个月、12个月和24个月时与基线相比没有统计学意义上的明显变化。98%的患者在治疗后仍能保持逆行射精:总之,研究结果表明,接受 Rezūm 治疗的患者在干预后的 24 个月内,IPSS、Qmax、PVR 和 IPSS 相关生活质量都有持续改善。98%的患者在治疗后仍能保持逆行射精。
{"title":"Efficacy of the Rezūm System for lower urinary tract symptoms in patients with benign prostatic hyperplasia: Long term results from a single centre prospective study.","authors":"Angelo Totaro, Filippo Gavi, Daniele Fettucciari, Francesco Pio Bizzarri, Domenico Sanesi, Luigi Cosenza, Filippo Marino, Antonio Cretì, Pierluigi Russo, Emilio Sacco","doi":"10.1177/03915603241297137","DOIUrl":"https://doi.org/10.1177/03915603241297137","url":null,"abstract":"<p><strong>Introduction: </strong>Benign prostatic hyperplasia (BPH) is a prevalent urological condition leading to lower urinary tract symptoms. Minimal invasive surgical treatment (MISTs) such as Rezūm System are emerging aiming to relieve symptoms. We present results from a single centre prospective study.</p><p><strong>Methods: </strong>We prospectively followed patients undergoing Rezūm between 2021 and 2023 from a single centre. International Prostate Symptom Score (IPSS), functional outcomes (maximum urinary flow rate (Qmax) and post-void urinary residual (PVR) and International Index of Erectile Function-5 (IIEF-5) were assessed at 3, 6, 12 and 24 months. Anterograde ejaculation was assessed at 12 months follow up. Linear mixed-effects models (LMMs) for repeated measures were applied to assess differences in the IPSS, maximum flow rate (Qmax), PVR, and International Index of Erectile Function-5 (IIEF-5) from baseline (t0) to 3, 6, 12 and 24 months. Results: After adjusting for prostate volume and symptoms severity, significant differences were observed at 3, 6, 12 and 24 months for IPSS (<i>p</i> < 0.001), Qmax (<i>p</i> < 0.001), PVR (<i>p</i> < 0.001) and IPSS-QoL (<i>p</i> < 0.001) from baseline. No statistically significant changes were found in the IIEF-5 scores at 3, 6, 12 and 24 months from baseline. Anterograde ejaculation remained in 98% of patients after treatment.</p><p><strong>Conclusions: </strong>In conclusion, the study's findings indicate that patients undergoing Rezūm treatment experience sustained improvements in IPSS, Qmax, PVR and IPSS-related quality of life up to 24 months following the intervention. Anterograde ejaculation remained in 98% of patients after treatment.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603241297137"},"PeriodicalIF":0.8,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare complication after ureterorenoscopy lithotripsy: Subcapsular renal hematoma. 输尿管镜碎石术后的罕见并发症:肾下血肿。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-07 DOI: 10.1177/03915603241292842
Xiaofei Lu, Yingchao Chen, Weiliang Cao, Zhiyong Ding, Benzheng Zhou

Objective: To evaluate the prevalence, risk factors, clinical manifestations, and outcomes of subcapsular renal hematoma (SRH) following ureterolithotripsy.

Patients and methods: Between January 2014 and December 2023, patients who underwent ureterorenoscopy lithotripsy (URL) at our hospital were retrospectively reviewed. Clinical data including basic information, calculi-related indicators, and perioperative period data were collected. A Student's t-test was used for continuous data, while a Chi-square test or Fisher's exact test was utilized for categorical data.

Results: A total of 2098 patients treated with URL for ureteric stones were included in this study. The incidence of SRH after URL was 0.52% (11 cases). All SRH cases were confirmed by non-contrast computed tomography, with an average patient age of 55.54 years (range 34-84). The mean stone size in patients with SRH was 10.54 cm (range 0.8-1.5). Patients with SRH had a higher proportion of severe hydronephrosis caused by ureteral stones (54.55% vs 26.07%, p = 0.032) and narrow ureters (45.45% vs 8.04%, p < 0.001) compared to those without SRH. Patients with SRH experienced a longer length of stay, with a significant difference between the two groups (11.64 ± 5.05 vs 3.87 ± 8.12, p < 0.001). Nine patients were managed conservatively without further intervention, while embolization was required in one patient and percutaneous drainage was performed in another. All SRH cases resolved completely during a 4-month follow-up.

Conclusions: The incidence of SRH following URL is low, with severe hydronephrosis and narrow ureters identified as risk factors. Most SRH cases can be successfully managed conservatively, although patients with SRH may experience a significant prolongation of their length of stay.

目的评估输尿管碎石术后肾囊下血肿(SRH)的发病率、风险因素、临床表现和预后:回顾性研究2014年1月至2023年12月期间在我院接受输尿管镜碎石术(URL)的患者。收集临床数据,包括基本信息、计算相关指标和围手术期数据。连续性数据采用学生 t 检验,分类数据采用卡方检验或费雪精确检验:结果:共有2098名输尿管结石患者接受了URL治疗。URL后SRH的发生率为0.52%(11例)。所有SRH病例均通过非对比计算机断层扫描确认,患者平均年龄为55.54岁(34-84岁不等)。SRH患者的平均结石大小为10.54厘米(范围为0.8-1.5)。SRH 患者因输尿管结石(54.55% 对 26.07%,P = 0.032)和输尿管狭窄(45.45% 对 8.04%,P P 结论)导致严重肾积水的比例更高:URL 后 SRH 的发生率较低,严重肾积水和输尿管狭窄被认为是风险因素。虽然 SRH 患者的住院时间可能会显著延长,但大多数 SRH 病例都能成功地通过保守治疗得到控制。
{"title":"A rare complication after ureterorenoscopy lithotripsy: Subcapsular renal hematoma.","authors":"Xiaofei Lu, Yingchao Chen, Weiliang Cao, Zhiyong Ding, Benzheng Zhou","doi":"10.1177/03915603241292842","DOIUrl":"https://doi.org/10.1177/03915603241292842","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the prevalence, risk factors, clinical manifestations, and outcomes of subcapsular renal hematoma (SRH) following ureterolithotripsy.</p><p><strong>Patients and methods: </strong>Between January 2014 and December 2023, patients who underwent ureterorenoscopy lithotripsy (URL) at our hospital were retrospectively reviewed. Clinical data including basic information, calculi-related indicators, and perioperative period data were collected. A Student's <i>t</i>-test was used for continuous data, while a Chi-square test or Fisher's exact test was utilized for categorical data.</p><p><strong>Results: </strong>A total of 2098 patients treated with URL for ureteric stones were included in this study. The incidence of SRH after URL was 0.52% (11 cases). All SRH cases were confirmed by non-contrast computed tomography, with an average patient age of 55.54 years (range 34-84). The mean stone size in patients with SRH was 10.54 cm (range 0.8-1.5). Patients with SRH had a higher proportion of severe hydronephrosis caused by ureteral stones (54.55% vs 26.07%, <i>p</i> = 0.032) and narrow ureters (45.45% vs 8.04%, <i>p</i> < 0.001) compared to those without SRH. Patients with SRH experienced a longer length of stay, with a significant difference between the two groups (11.64 ± 5.05 vs 3.87 ± 8.12, <i>p</i> < 0.001). Nine patients were managed conservatively without further intervention, while embolization was required in one patient and percutaneous drainage was performed in another. All SRH cases resolved completely during a 4-month follow-up.</p><p><strong>Conclusions: </strong>The incidence of SRH following URL is low, with severe hydronephrosis and narrow ureters identified as risk factors. Most SRH cases can be successfully managed conservatively, although patients with SRH may experience a significant prolongation of their length of stay.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603241292842"},"PeriodicalIF":0.8,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New masculinities in uro-oncology: A social theory that contributes to the mental health of patients with penile cancer. 泌尿肿瘤学中的新男子气概:有助于阴茎癌患者心理健康的社会理论。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-07 DOI: 10.1177/03915603241293840
Natalia Barbosa Daza, Daniel Andrés Nieva-Posso, Herney Andrés García-Perdomo

Sociocultural, the penis has represented an essential element in the identity and masculinity of Western men. Therefore, its injury, damage, or loss leads to psychosocial problems affecting these people's health and well-being. Penile cancer is a rare malignancy (it represents 1.44% of the cases of genitourinary cancers) that has direct effects on the genitals, and its treatment consists of penectomy (removal of the penis). The loss of the penis due to this disease has a profound impact on the survivors. It is associated with higher rates of depression, anxiety, and loss of male identity, some even feeling like "castrated animals" or fewer men, having not only biological but also social and psychological problems, leading to the loss or decrease of sexual activity, self-esteem, and ability to relate to others. The new masculinities (a social theory much discussed these days) is offered as an alternative to understanding the behavior of men concerning what represents the penis, and the construction of their identity, focusing on the need to reconstruct the idea of masculinity and unlink the identity of men outside their genitals, the discussion of such social elements can be offered alternatives to help improve the psychological condition of patients who have survived the penectomy and contribute significantly to their health and quality of life, especially in improving your mental health.

在社会文化方面,阴茎代表了西方男性身份和男性气质的一个基本要素。因此,阴茎的损伤、损坏或丢失会导致社会心理问题,影响这些人的健康和幸福。阴茎癌是一种罕见的直接影响生殖器的恶性肿瘤(占泌尿生殖系统癌症病例的 1.44%),其治疗方法包括阴茎切除术(切除阴茎)。这种疾病导致的阴茎缺失对幸存者影响深远。抑郁、焦虑和丧失男性身份的比例较高,有些人甚至觉得自己像 "被阉割的动物 "或更少的男人,不仅有生理问题,还有社会和心理问题,导致性活动、自尊和与他人相处的能力丧失或下降。新男子气概(最近讨论较多的一种社会理论)是作为一种替代方案来理解男性关于阴茎代表什么的行为,以及他们身份的构建,重点是需要重建男子气概的理念,并解除男性在生殖器之外的身份联系,对这些社会因素的讨论可以提供替代方案,帮助改善阴茎切除术后幸存患者的心理状况,并极大地促进他们的健康和生活质量,尤其是改善您的心理健康。
{"title":"New masculinities in uro-oncology: A social theory that contributes to the mental health of patients with penile cancer.","authors":"Natalia Barbosa Daza, Daniel Andrés Nieva-Posso, Herney Andrés García-Perdomo","doi":"10.1177/03915603241293840","DOIUrl":"https://doi.org/10.1177/03915603241293840","url":null,"abstract":"<p><p>Sociocultural, the penis has represented an essential element in the identity and masculinity of Western men. Therefore, its injury, damage, or loss leads to psychosocial problems affecting these people's health and well-being. Penile cancer is a rare malignancy (it represents 1.44% of the cases of genitourinary cancers) that has direct effects on the genitals, and its treatment consists of penectomy (removal of the penis). The loss of the penis due to this disease has a profound impact on the survivors. It is associated with higher rates of depression, anxiety, and loss of male identity, some even feeling like \"castrated animals\" or fewer men, having not only biological but also social and psychological problems, leading to the loss or decrease of sexual activity, self-esteem, and ability to relate to others. The new masculinities (a social theory much discussed these days) is offered as an alternative to understanding the behavior of men concerning what represents the penis, and the construction of their identity, focusing on the need to reconstruct the idea of masculinity and unlink the identity of men outside their genitals, the discussion of such social elements can be offered alternatives to help improve the psychological condition of patients who have survived the penectomy and contribute significantly to their health and quality of life, especially in improving your mental health.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603241293840"},"PeriodicalIF":0.8,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor morphology evaluation using 3D-morphometric features of renal masses. 利用肾肿块的三维形态特征评估肿瘤形态。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-26 DOI: 10.1177/03915603241261499
Fiev Dmitry, Sirota Evgeniy, Kozlov Vasiliy, Proskura Alexandra, Ismailov Khalil, Shpot Evgeny, Chernenkiy Mikhail, Puzakov Kirill, Tarasov Alexander, Korolev Dmitry, Azilgareeva Camilla, Vinarov Andrey, Butnaru Denis, Glybochko Petr, Rapoport Leonid

Objective: To assess the correlation between the general (gender, age, and maximum tumor size) and 3D morphotopometric features of the renal tumor node, following the MSCT data post-processing, and the tumor histological structure; to propose an equation allowing for kidney malignancy assessment based on general and morphometric features.

Materials and methods: In total, 304 patients with unilateral solitary renal neoplasms underwent laparoscopic (retroperitoneoscopic) or robotic partial or radical nephrectomy. Before the procedure, kidney contrast-enhanced MSCT followed by the tumor 3D-modeling was performed. 3D model of the kidney tumor, and its morphotopometric features, and histological structure were analyzed. The morphotopometric ones include the side of the lesion, location by segments, the surface where the tumor, the depth of the tumor invasion into the kidney, and the shape of tumor.

Results: Out of 304 patients, 254 (83.6%) had malignant kidney tumors and 50 (16.4%) benign kidney tumors. In total, 231 patients, out of 254 (90.9%) were assessed for the degree of malignant tumor differentiation. Malignant tumors were more frequent in men than in women (p < 0.001). Mushroom-shaped tumors were the most common shapes among benign renal masses (35.2%). The most common malignant kidney tumors had spherical with a partially uneven surface (27.6%), multinodular (tuberous (27.2%)), and spherical with a conical base (24.8%) shapes. Logistic regression model enabled the development of prognostic equation for tumor malignancy prediction ("low" or "high"). The univariate analysis revealed the correlation only between high differentiation (G1) and a spherical tumor with a conical base (p = 0.029).

Conclusion: The resulting logistic model, based on the analysis of such predictors as gender and form of kidney lesions, demonstrated a large share (87.6%) of correct predictions of the kidney tumor malignancy.

目的评估经 MSCT 数据后处理的肾脏肿瘤结节的一般特征(性别、年龄和最大肿瘤大小)和三维形态计量特征与肿瘤组织学结构之间的相关性;提出一种根据一般特征和形态计量特征评估肾脏恶性程度的公式:共有 304 例单侧单发肾肿瘤患者接受了腹腔镜(后腹腔镜)或机器人肾部分或根治性切除术。术前进行肾脏造影剂增强 MSCT,然后进行肿瘤三维建模。对肾脏肿瘤的三维模型、形态计量特征和组织学结构进行了分析。形态计量特征包括病变的侧位、分段位置、肿瘤所在的表面、肿瘤侵入肾脏的深度以及肿瘤的形状:在 304 名患者中,254 人(83.6%)患有恶性肾肿瘤,50 人(16.4%)患有良性肾肿瘤。在 254 名患者中,共有 231 名患者(90.9%)接受了恶性肿瘤分化程度评估。男性患恶性肿瘤的比例高于女性(P = 0.029):根据对性别和肾脏病变形式等预测因素的分析,得出的逻辑模型对肾脏肿瘤恶性程度的预测正确率很高(87.6%)。
{"title":"Tumor morphology evaluation using 3D-morphometric features of renal masses.","authors":"Fiev Dmitry, Sirota Evgeniy, Kozlov Vasiliy, Proskura Alexandra, Ismailov Khalil, Shpot Evgeny, Chernenkiy Mikhail, Puzakov Kirill, Tarasov Alexander, Korolev Dmitry, Azilgareeva Camilla, Vinarov Andrey, Butnaru Denis, Glybochko Petr, Rapoport Leonid","doi":"10.1177/03915603241261499","DOIUrl":"10.1177/03915603241261499","url":null,"abstract":"<p><strong>Objective: </strong>To assess the correlation between the general (gender, age, and maximum tumor size) and 3D morphotopometric features of the renal tumor node, following the MSCT data post-processing, and the tumor histological structure; to propose an equation allowing for kidney malignancy assessment based on general and morphometric features.</p><p><strong>Materials and methods: </strong>In total, 304 patients with unilateral solitary renal neoplasms underwent laparoscopic (retroperitoneoscopic) or robotic partial or radical nephrectomy. Before the procedure, kidney contrast-enhanced MSCT followed by the tumor 3D-modeling was performed. 3D model of the kidney tumor, and its morphotopometric features, and histological structure were analyzed. The morphotopometric ones include the side of the lesion, location by segments, the surface where the tumor, the depth of the tumor invasion into the kidney, and the shape of tumor.</p><p><strong>Results: </strong>Out of 304 patients, 254 (83.6%) had malignant kidney tumors and 50 (16.4%) benign kidney tumors. In total, 231 patients, out of 254 (90.9%) were assessed for the degree of malignant tumor differentiation. Malignant tumors were more frequent in men than in women (<i>p</i> < 0.001). Mushroom-shaped tumors were the most common shapes among benign renal masses (35.2%). The most common malignant kidney tumors had spherical with a partially uneven surface (27.6%), multinodular (tuberous (27.2%)), and spherical with a conical base (24.8%) shapes. Logistic regression model enabled the development of prognostic equation for tumor malignancy prediction (\"low\" or \"high\"). The univariate analysis revealed the correlation only between high differentiation (G1) and a spherical tumor with a conical base (<i>p</i> = 0.029).</p><p><strong>Conclusion: </strong>The resulting logistic model, based on the analysis of such predictors as gender and form of kidney lesions, demonstrated a large share (87.6%) of correct predictions of the kidney tumor malignancy.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"665-673"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of efficacy and safety of Botulinum toxin-A injection at three deferent sites in treatment of premature ejaculation. 评估在三个不同部位注射肉毒杆菌毒素 A 治疗早泄的有效性和安全性。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-02 DOI: 10.1177/03915603241265825
Ahmed Rashad Elshahid, Abobakr Osama Abdel-Goad Taher, Ahmed Hassan Nouh

Background: Premature ejaculation (PE) is a common sexual problem, resulting in adverse effects on the quality of life, of both the patient and the partner. The idea of muscular contraction inhibition during the ejection phase of ejaculation by Botulinum toxin-A injection may delay ejaculation.

Aim of study: This study was performed to assess the efficacy and safety of Botulinum toxin-A injection in PE treatment.

Material and methods: This study included 45 married male patients diagnosed with primary PE. All included patients were injected with 75 units of Dysport equal efficacy of 25 units of Botulinum toxin-A (Botox) into three sites: the root of the penis (Group 1), glans penis (Group 2), and each side of the ischiocavernosus muscle (Group 3). All patients were subjected to an assessment of intravaginal ejaculation latency time (IELT) using a stopwatch and answering the Premature Ejaculation Diagnostic Tool (PEDT) Questionnaire before and after treatment.

Results: There was a statistically significant improvement in IELT after treatment in all groups. The most significant improvement was shown in Group 3 (average 108% increase), followed by Group 1 (74%) and Group 2 (40%), respectively. There was a positive correlation between age and the improvement in improved IELT. There was a statistically significant improvement in PEDTq scores in Group 1 and Group 3.

Conclusion: Botulinum toxin-A injection into the root of the penis and ischiocavernosus muscle could be recommended in the treatment of premature ejaculation.

背景:早泄(PE)是一种常见的性问题,会对患者和伴侣的生活质量造成不良影响。通过注射肉毒杆菌毒素-A抑制射精阶段的肌肉收缩,可以延缓射精:本研究旨在评估肉毒杆菌毒素A注射液治疗PE的有效性和安全性:本研究包括45名被诊断为原发性PE的已婚男性患者。所有患者均在三个部位(阴茎根部(第 1 组)、阴茎龟头(第 2 组)和阴茎海绵体肌两侧(第 3 组))注射了 75 单位 Dysport 和 25 单位肉毒杆菌毒素 A(Botox)。所有患者在治疗前后均使用秒表评估阴道内射精潜伏时间(IELT),并回答早泄诊断工具(PEDT)问卷:各组治疗后的射精延迟时间均有明显改善。第 3 组的改善最为明显(平均提高 108%),其次分别是第 1 组(74%)和第 2 组(40%)。年龄与 IELT 的改善呈正相关。第一组和第三组的 PEDTq 评分在统计学上有明显改善:结论:在阴茎根部和阴茎海绵体肌注射肉毒杆菌毒素 A 可用于治疗早泄。
{"title":"Evaluation of efficacy and safety of Botulinum toxin-A injection at three deferent sites in treatment of premature ejaculation.","authors":"Ahmed Rashad Elshahid, Abobakr Osama Abdel-Goad Taher, Ahmed Hassan Nouh","doi":"10.1177/03915603241265825","DOIUrl":"10.1177/03915603241265825","url":null,"abstract":"<p><strong>Background: </strong>Premature ejaculation (PE) is a common sexual problem, resulting in adverse effects on the quality of life, of both the patient and the partner. The idea of muscular contraction inhibition during the ejection phase of ejaculation by Botulinum toxin-A injection may delay ejaculation.</p><p><strong>Aim of study: </strong>This study was performed to assess the efficacy and safety of Botulinum toxin-A injection in PE treatment.</p><p><strong>Material and methods: </strong>This study included 45 married male patients diagnosed with primary PE. All included patients were injected with 75 units of Dysport equal efficacy of 25 units of Botulinum toxin-A (Botox) into three sites: the root of the penis (Group 1), glans penis (Group 2), and each side of the ischiocavernosus muscle (Group 3). All patients were subjected to an assessment of intravaginal ejaculation latency time (IELT) using a stopwatch and answering the Premature Ejaculation Diagnostic Tool (PEDT) Questionnaire before and after treatment.</p><p><strong>Results: </strong>There was a statistically significant improvement in IELT after treatment in all groups. The most significant improvement was shown in Group 3 (average 108% increase), followed by Group 1 (74%) and Group 2 (40%), respectively. There was a positive correlation between age and the improvement in improved IELT. There was a statistically significant improvement in PEDTq scores in Group 1 and Group 3.</p><p><strong>Conclusion: </strong>Botulinum toxin-A injection into the root of the penis and ischiocavernosus muscle could be recommended in the treatment of premature ejaculation.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"824-829"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study. 口服补充益生菌、柠檬酸钾和镁可减少结石患者的结晶尿:二期研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-29 DOI: 10.1177/03915603241272146
Matteo Vittori, Pierluigi Bove, Marta Signoretti, Chiara Cipriani, Cristiano Gasparoli, Michele Antonucci, Marco Carilli, Francesco Maiorino, Valerio Iacovelli, Filomena Petta, Stefano Travaglia, Massimo Panei, Pierluigi Russo, Riccardo Bertolo

Introduction: Crystalluria is an important indicator of renal stone recurrence. Mechanisms underlying urinary stone formation are still not fully understood and raising interests has been giving to intestinal commensal bacteria for their contribute in maintaining urinary solutes equilibrium. The aim of our phase II study was to examine the administration of potassium citrate, magnesium and probiotics in order to reduce crystalluria.

Materials and methods: Since May 2021, we enrolled 23 patients candidates for ureterorenolithotripsy for calcium oxalate kidney stones with crystalluria and a normal metabolic profile. The analysis was validated by the Institution's Ethical Committee (no. approval STS CE Lazio 1/N-823). At discharge, patients were provided with daily food supplementation for 20 days of 1 billion Lactobacillus paracasei LPC09, 1 billion Lactobacillus plantarum LP01, 1 billion Bifidobacterium breve BR03, potassium (520 mg), citrate (1400 mg), and magnesium (80 mg). Crystalluria was re-assessed at 1, 3, 6, and 12-months follow-up by polarized light microscopy.

Results: After one month from the oral supplementation, no patient reported crystalluria; at 3 months, among the 20 participants available for re-evaluation, still no patient reported crystalluria. Instead, crystalluria was reported in three patients (15%) at 6 months, and in five patients (25%) at 12 months follow-up.

Conclusions: The oral supplementation with Lactobacillus spp. and Bifidobacterium spp. was found able to reduce the prevalence of crystalluria in a cohort of patients with diagnosis of calcium oxalate kidney stones with crystalluria candidate to ureterorenolithotripsy.

导言:结晶尿是肾结石复发的一个重要指标。人们对尿路结石的形成机制仍不完全清楚,因此对肠道共生菌在维持尿液溶质平衡方面的作用产生了浓厚的兴趣。我们的 II 期研究旨在探讨枸橼酸钾、镁和益生菌对减少结晶尿的作用:自 2021 年 5 月起,我们招募了 23 名草酸钙肾结石输尿管结石碎石术候选患者,这些患者均有结晶尿,且代谢状况正常。该分析已获得该机构伦理委员会的批准(批准号为 STS CE Lazio 1/N-823)。出院时,患者每天补充 10 亿个副干酪乳杆菌 LPC09、10 亿个植物乳杆菌 LP01、10 亿个乳双歧杆菌 BR03、钾(520 毫克)、柠檬酸盐(1400 毫克)和镁(80 毫克),为期 20 天。在随访 1、3、6 和 12 个月时,用偏光显微镜再次评估结晶:结果:口服补充剂一个月后,没有患者报告出现结晶尿;3 个月后,在 20 名可接受再次评估的参与者中,仍没有患者报告出现结晶尿。而在 6 个月和 12 个月的随访中,分别有 3 名患者(15%)和 5 名患者(25%)出现结晶尿:结论:口服乳酸杆菌和双歧杆菌能降低草酸钙肾结石患者结晶尿的发病率,这些患者都是输尿管肾镜碎石术的结晶尿候选者。
{"title":"Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study.","authors":"Matteo Vittori, Pierluigi Bove, Marta Signoretti, Chiara Cipriani, Cristiano Gasparoli, Michele Antonucci, Marco Carilli, Francesco Maiorino, Valerio Iacovelli, Filomena Petta, Stefano Travaglia, Massimo Panei, Pierluigi Russo, Riccardo Bertolo","doi":"10.1177/03915603241272146","DOIUrl":"10.1177/03915603241272146","url":null,"abstract":"<p><strong>Introduction: </strong>Crystalluria is an important indicator of renal stone recurrence. Mechanisms underlying urinary stone formation are still not fully understood and raising interests has been giving to intestinal commensal bacteria for their contribute in maintaining urinary solutes equilibrium. The aim of our phase II study was to examine the administration of potassium citrate, magnesium and probiotics in order to reduce crystalluria.</p><p><strong>Materials and methods: </strong>Since May 2021, we enrolled 23 patients candidates for ureterorenolithotripsy for calcium oxalate kidney stones with crystalluria and a normal metabolic profile. The analysis was validated by the Institution's Ethical Committee (no. approval STS CE Lazio 1/N-823). At discharge, patients were provided with daily food supplementation for 20 days of 1 billion Lactobacillus paracasei LPC09, 1 billion Lactobacillus plantarum LP01, 1 billion Bifidobacterium breve BR03, potassium (520 mg), citrate (1400 mg), and magnesium (80 mg). Crystalluria was re-assessed at 1, 3, 6, and 12-months follow-up by polarized light microscopy.</p><p><strong>Results: </strong>After one month from the oral supplementation, no patient reported crystalluria; at 3 months, among the 20 participants available for re-evaluation, still no patient reported crystalluria. Instead, crystalluria was reported in three patients (15%) at 6 months, and in five patients (25%) at 12 months follow-up.</p><p><strong>Conclusions: </strong>The oral supplementation with Lactobacillus spp. and Bifidobacterium spp. was found able to reduce the prevalence of crystalluria in a cohort of patients with diagnosis of calcium oxalate kidney stones with crystalluria candidate to ureterorenolithotripsy.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"681-686"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive values and relationships of serum PSA levels, delta neutrophil index, neutrophil-lymphocyte ratio and other hematological parameters in patients with acute prostatitis. 急性前列腺炎患者血清 PSA 水平、delta 中性粒细胞指数、中性粒细胞-淋巴细胞比率及其他血液学参数的预测价值和关系。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-09-02 DOI: 10.1177/03915603241273883
Bekir Sami Uyanık, Basri Cakiroglu, Ramazan Gozukucuk

Background: This study aimed to evaluate the predictive values and relationships of serum prostate-specific antigen (PSA) levels, delta neutrophil index (DNI), neutrophil-lymphocyte ratio (NLR), and other hematological parameters in patients diagnosed with acute prostatitis.

Methods: Serum PSA levels and hemogram parameters of patients diagnosed with acute prostatitis were retrospectively analyzed. Healthy patients of the same age group were assigned to the control group. WBC, neutrophil, lymphocyte, thrombocyte (PLT), mean platelet volume (MPV), plateletcrit (PCT), NLR, and DNI were determined. Serum total PSA and C-reactive protein (CRP) levels were also assessed.

Results: Total PSA levels (3.48 [1.11-6.66]) in the acute prostatitis (AP) group were significantly higher than those of healthy men (0.82 [0.47-1.39]) (p < 0.001). Total CRP levels (3.88 [1.50-22.03]) in the AP group were significantly higher than those in healthy men (1.15 [0.89-2.00]) (p < 0.001). The sensitivity and specificity of PSA at a cutoff value of 1.52 were 68.4% and 79.7%, respectively. The NLR value in the AP group was 2.62 (1.87-4.42), compared to 1.63 (1.18-2.20) in the healthy group (p < 0.001). Differences in WBC, neutrophil, and lymphocyte counts were also statistically significant (p < 0.001). There were no significant differences in PLT, PCT, or DNI values. Significant positive correlations were observed between PSA, CRP, and DNI values (all p < 0.001).

Conclusion: This study demonstrated the usefulness of NLR, PSA, CRP, and WBC as predictors of acute prostatitis. NLR is a simple, inexpensive inflammation parameter that correlates well with CRP levels.

研究背景本研究旨在评估急性前列腺炎患者血清前列腺特异性抗原(PSA)水平、δ中性粒细胞指数(DNI)、中性粒细胞-淋巴细胞比值(NLR)和其他血液学参数的预测价值和关系:方法:对确诊为急性前列腺炎患者的血清 PSA 水平和血液学参数进行回顾性分析。将同年龄组的健康患者列为对照组。测定白细胞、中性粒细胞、淋巴细胞、血小板(PLT)、平均血小板体积(MPV)、血小板比容(PCT)、NLR和DNI。此外,还评估了血清总 PSA 和 C 反应蛋白 (CRP) 水平:本研究证明了 NLR、PSA、CRP 和 WBC 作为急性前列腺炎预测指标的实用性。NLR 是一种简单、廉价的炎症参数,与 CRP 水平有很好的相关性。
{"title":"Predictive values and relationships of serum PSA levels, delta neutrophil index, neutrophil-lymphocyte ratio and other hematological parameters in patients with acute prostatitis.","authors":"Bekir Sami Uyanık, Basri Cakiroglu, Ramazan Gozukucuk","doi":"10.1177/03915603241273883","DOIUrl":"10.1177/03915603241273883","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the predictive values and relationships of serum prostate-specific antigen (PSA) levels, delta neutrophil index (DNI), neutrophil-lymphocyte ratio (NLR), and other hematological parameters in patients diagnosed with acute prostatitis.</p><p><strong>Methods: </strong>Serum PSA levels and hemogram parameters of patients diagnosed with acute prostatitis were retrospectively analyzed. Healthy patients of the same age group were assigned to the control group. WBC, neutrophil, lymphocyte, thrombocyte (PLT), mean platelet volume (MPV), plateletcrit (PCT), NLR, and DNI were determined. Serum total PSA and C-reactive protein (CRP) levels were also assessed.</p><p><strong>Results: </strong>Total PSA levels (3.48 [1.11-6.66]) in the acute prostatitis (AP) group were significantly higher than those of healthy men (0.82 [0.47-1.39]) (<i>p</i> < 0.001). Total CRP levels (3.88 [1.50-22.03]) in the AP group were significantly higher than those in healthy men (1.15 [0.89-2.00]) (<i>p</i> < 0.001). The sensitivity and specificity of PSA at a cutoff value of 1.52 were 68.4% and 79.7%, respectively. The NLR value in the AP group was 2.62 (1.87-4.42), compared to 1.63 (1.18-2.20) in the healthy group (<i>p</i> < 0.001). Differences in WBC, neutrophil, and lymphocyte counts were also statistically significant (<i>p</i> < 0.001). There were no significant differences in PLT, PCT, or DNI values. Significant positive correlations were observed between PSA, CRP, and DNI values (all <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>This study demonstrated the usefulness of NLR, PSA, CRP, and WBC as predictors of acute prostatitis. NLR is a simple, inexpensive inflammation parameter that correlates well with CRP levels.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"775-780"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social media and urology: The good, the bad and the ugly. 社交媒体与泌尿外科:好、坏、丑。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-30 DOI: 10.1177/03915603241273885
Patrick Juliebø-Jones, Vineet Gauhar, Etienne Xavier Keller, Vincent De Coninck, Ali Talyshinskii, Alba Sierra, Eugenio Ventimiglia, Lazaros Tzelves, Mariela Corrales, Esteban Emiliani, Christian Beisland, Bhaskar K Somani

Social media (SoMe) is now a core part of modern-day life with increased use among both patients and urologists. The interplay of SoMe between these two parties is complex. From a patient perspective, SoMe platforms can serve as educational tools as well as communication portals to support networks and patient communities. However, studies report the educational value of content online is often poor and may contain misinformation. For urologists, SoMe can lead to research collaborations, networking and educational content but areas of concern include the potential negative impact SoMe can have on mental health and sharing of patient images without appropriate consent. This review serves to provide an overview of the interaction between SoMe and urology practice and provide practical guidance to navigating it.

社交媒体 (SoMe) 如今已成为现代生活的核心部分,患者和泌尿科医生都越来越多地使用社交媒体。SoMe 在双方之间的相互作用十分复杂。从患者的角度来看,SoMe 平台既可以作为教育工具,也可以作为支持网络和患者社区的交流门户。然而,研究报告显示,在线内容的教育价值往往很低,而且可能包含错误信息。对于泌尿科医生来说,SoMe 可以带来研究合作、网络和教育内容,但令人担忧的方面包括 SoMe 对心理健康的潜在负面影响以及未经适当同意共享患者图像。本综述旨在概述 SoMe 与泌尿外科实践之间的互动关系,并为如何驾驭 SoMe 提供实用指导。
{"title":"Social media and urology: The good, the bad and the ugly.","authors":"Patrick Juliebø-Jones, Vineet Gauhar, Etienne Xavier Keller, Vincent De Coninck, Ali Talyshinskii, Alba Sierra, Eugenio Ventimiglia, Lazaros Tzelves, Mariela Corrales, Esteban Emiliani, Christian Beisland, Bhaskar K Somani","doi":"10.1177/03915603241273885","DOIUrl":"10.1177/03915603241273885","url":null,"abstract":"<p><p>Social media (SoMe) is now a core part of modern-day life with increased use among both patients and urologists. The interplay of SoMe between these two parties is complex. From a patient perspective, SoMe platforms can serve as educational tools as well as communication portals to support networks and patient communities. However, studies report the educational value of content online is often poor and may contain misinformation. For urologists, SoMe can lead to research collaborations, networking and educational content but areas of concern include the potential negative impact SoMe can have on mental health and sharing of patient images without appropriate consent. This review serves to provide an overview of the interaction between SoMe and urology practice and provide practical guidance to navigating it.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"659-664"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the safety of bladder-preserving therapy as an alternative to surgical intervention in elderly patients with muscle invasive bladder cancer. 评估肌肉浸润性膀胱癌老年患者采用膀胱保留疗法替代手术治疗的安全性。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-26 DOI: 10.1177/03915603241265828
Christopher R Koller, Jacob W Greenberg, Caleb Natale, L Spencer Krane

Background: There is interest in using bladder-preserving therapy as an alternative definitive therapy for muscle invasive bladder cancer in certain high-risk groups such as the elderly.

Objective: To determine if bladder-preserving therapy represents a safer alternative to surgical intervention in elderly patients with muscle invasive bladder cancer.

Methods: We surveyed the Surveillance, Epidemiology and End Results database (SEER) for cases of non-metastasized malignant bladder cancer in patients aged 80+. Survival outcomes with radical cystectomy (RC) with or without chemotherapy were compared to those after chemotherapy and radiation without cystectomy. We performed log-rank tests and Kaplan-Meier and cox regression and hazard analyses before and after propensity score matching.

Results: A total of 2995 patients were identified, with 49.98% treated with RC only, 8.65% treated with RC/chemotherapy, and 41.37% treated with chemotherapy and radiation without RC. Median overall survival for the RC only, RC/chemotherapy and chemotherapy/radiation groups were 31.4, 44.1, and 24.6 months, respectively. On multivariate analysis, hazard ratios (reference: RC/chemotherapy group) were RC Only (HR = 1.408 (95% CI 1.188-1.669), p < 0.0001) and chemotherapy/radiation (HR = 1.650 (95% CI 1.390-1.959), p < 0.0001). After matching the chemotherapy/radiation and RC/chemotherapy groups, the former continued to show survival hazard (HR = 1.744 (95% CI 1.414-2.155), p < 0.0001).

Conclusions: Octogenarians should be offered definitive local therapy for their localized bladder cancer including RC and chemotherapy. Bladder-sparing alternatives should be reserved for patients unfit for surgery.

背景:在某些高危人群(如老年人)中,使用膀胱保留疗法作为肌层浸润性膀胱癌的替代性最终疗法受到关注:目的:确定对老年肌层浸润性膀胱癌患者而言,膀胱保留疗法是否是一种更安全的手术干预替代疗法:我们调查了监测、流行病学和最终结果数据库(SEER)中80岁以上非转移性恶性膀胱癌患者的病例。比较了根治性膀胱切除术(RC)加或不加化疗与化疗和放疗后不进行膀胱切除术的生存结果。我们对倾向评分匹配前后的结果进行了对数秩检验、卡普兰-梅耶(Kaplan-Meier)分析、cox回归分析和危险分析:共有 2995 例患者接受了治疗,其中 49.98% 的患者仅接受了 RC 治疗,8.65% 的患者接受了 RC/化疗,41.37% 的患者接受了化疗和放疗,但未接受 RC 治疗。仅接受 RC 治疗组、RC/化疗组和化疗/放疗组的中位总生存期分别为 31.4 个月、44.1 个月和 24.6 个月。经多变量分析,危险比(参考:RC/化疗组)为仅 RC(HR = 1.408 (95% CI 1.188-1.669), p p p 结论:八旬老人的局部膀胱癌应接受明确的局部治疗,包括RC和化疗。对于不适合手术的患者,应保留保留膀胱的替代方案。
{"title":"Assessing the safety of bladder-preserving therapy as an alternative to surgical intervention in elderly patients with muscle invasive bladder cancer.","authors":"Christopher R Koller, Jacob W Greenberg, Caleb Natale, L Spencer Krane","doi":"10.1177/03915603241265828","DOIUrl":"10.1177/03915603241265828","url":null,"abstract":"<p><strong>Background: </strong>There is interest in using bladder-preserving therapy as an alternative definitive therapy for muscle invasive bladder cancer in certain high-risk groups such as the elderly.</p><p><strong>Objective: </strong>To determine if bladder-preserving therapy represents a safer alternative to surgical intervention in elderly patients with muscle invasive bladder cancer.</p><p><strong>Methods: </strong>We surveyed the Surveillance, Epidemiology and End Results database (SEER) for cases of non-metastasized malignant bladder cancer in patients aged 80+. Survival outcomes with radical cystectomy (RC) with or without chemotherapy were compared to those after chemotherapy and radiation without cystectomy. We performed log-rank tests and Kaplan-Meier and cox regression and hazard analyses before and after propensity score matching.</p><p><strong>Results: </strong>A total of 2995 patients were identified, with 49.98% treated with RC only, 8.65% treated with RC/chemotherapy, and 41.37% treated with chemotherapy and radiation without RC. Median overall survival for the RC only, RC/chemotherapy and chemotherapy/radiation groups were 31.4, 44.1, and 24.6 months, respectively. On multivariate analysis, hazard ratios (reference: RC/chemotherapy group) were RC Only (HR = 1.408 (95% CI 1.188-1.669), <i>p</i> < 0.0001) and chemotherapy/radiation (HR = 1.650 (95% CI 1.390-1.959), <i>p</i> < 0.0001). After matching the chemotherapy/radiation and RC/chemotherapy groups, the former continued to show survival hazard (HR = 1.744 (95% CI 1.414-2.155), <i>p</i> < 0.0001).</p><p><strong>Conclusions: </strong>Octogenarians should be offered definitive local therapy for their localized bladder cancer including RC and chemotherapy. Bladder-sparing alternatives should be reserved for patients unfit for surgery.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"701-708"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologia Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1